ArticleCell reports2024
FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation.
Jie Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
42 papers cite it
this paperpooled itcites it
ArticleCell reports2024
Jie Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.